PfizerItem # 177510MPN 0409-1775-10

Dextrose Infant 25% 250 mg/mL 10 mL PFS, 10/Bx

In StockPrescription required

This item is prescription-controlled. A valid medical license must be on file for your account before it can be ordered.

25% Dextrose Injection, USP (For Infant Use)

Ansyr™ Plastic Syringe (Solution)

25% Dextrose Injection, USP is a sterile, nonpyrogenic, hypertonic solution of dextrose in water for injection administered by intravenous injection to restore blood glucose levels in hypoglycemia and as a source of carbohydrate calories.

NDC Units of Use: 00409-1775-40

NDC Units of Sale: 00409-1775-10

Concentration: 25% (250 mg/mL)

10 mL Ansyr Plastic Syringe

10 syringes per pack

Non-DEHP

Preservative-Free

Manufacturer: Pfizer
Sold By: Box of 10

What specific scenarios in neonatal care is the Dextrose Infant 25% solution ideal for?

The Dextrose Infant 25% solution is designed to restore blood glucose levels in neonates experiencing hypoglycemia and to provide a source of carbohydrate calories [Manufacturer Info].

When do situations typically require administering a 25% dextrose injection to an infant?

Administering a 25% dextrose injection is typically required in situations where an infant is experiencing significant hypoglycemia and needs rapid correction of their blood glucose levels [Manufacturer Info].

How does this product differ from other concentrations of dextrose injections?

This product, with a 25% concentration (250 mg/mL), offers a hypertonic solution, providing a higher dose of glucose per volume compared to lower concentration dextrose injections, making it suitable for severe hypoglycemia [Product Specs].

Are there any unique handling instructions for the Ansyr plastic syringe when used in a neonatal intensive care unit (NICU)?

The Ansyr plastic syringe should be handled with care to maintain sterility and prevent contamination; it is preservative-free and non-DEHP, ensuring safety in sensitive NICU environments [Product Specs].

What are the key safety precautions that clinicians should consider while administering this to infants?

Clinicians should ensure the solution is sterile before use, monitor infant glucose levels during administration to avoid potential hyperglycemia, and use the non-DEHP, preservative-free syringe to reduce risks of allergic reactions [Product Specs][Manufacturer Info].

Dextrose Infant 25% 250 mg/mL 10 mL PFS, 10/Bx

Dextrose Infant 25% 250 mg/mL 10 mL PFS, 10/Bx

Dextrose Infant 25% 250 mg/mL 10 mL PFS, 10/Bx

Frequently bought together

Aminophylline 250 mg/10 mL 25 mg/mL 10 mL SDV, 25/Bx

Lidocaine 2% 100 mg/5 mL 20 mg/mL 5 mL PFS, 10/Bx

Dextrose 50% 0.5 g/mL 25 g/50 mL 50 mL PFS, 10/Bx

Atropine Sulfate 0.1 mg/mL 1 mg/10 mL PFS No Needle, 10/Bx

Dextrose Infant 25% 250 mg/mL 10 mL PFS, 10/Bx

Frequently bought together

Aminophylline 250 mg/10 mL 25 mg/mL 10 mL SDV, 25/Bx

Lidocaine 2% 100 mg/5 mL 20 mg/mL 5 mL PFS, 10/Bx

Dextrose 50% 0.5 g/mL 25 g/50 mL 50 mL PFS, 10/Bx

Atropine Sulfate 0.1 mg/mL 1 mg/10 mL PFS No Needle, 10/Bx

Frequently bought together

Aminophylline 250 mg/10 mL 25 mg/mL 10 mL SDV, 25/Bx

Lidocaine 2% 100 mg/5 mL 20 mg/mL 5 mL PFS, 10/Bx

Dextrose 50% 0.5 g/mL 25 g/50 mL 50 mL PFS, 10/Bx

Atropine Sulfate 0.1 mg/mL 1 mg/10 mL PFS No Needle, 10/Bx

Frequently bought together

Aminophylline 250 mg/10 mL 25 mg/mL 10 mL SDV, 25/Bx

Lidocaine 2% 100 mg/5 mL 20 mg/mL 5 mL PFS, 10/Bx

Dextrose 50% 0.5 g/mL 25 g/50 mL 50 mL PFS, 10/Bx

Atropine Sulfate 0.1 mg/mL 1 mg/10 mL PFS No Needle, 10/Bx